  0086-18989305995        sales@mosinterchem.com

PRODUCTS DETAILS

Cilnidipine CAS 132203-70-4

Model: CAS: 132203-70-4
Place of Origin: Shandong,China (Mainland)
Brand: MOSINTER
Molecular Formula: C27H28N2O7
Specification: CP/USP/EP
Molecular Weight: 492.52
Melting point: 97-99°C

  • 132203-70-4
  • MOSINTER
  • 132203-70-4
Product Description

Payment & Shipping Terms

Supply Capacity

Payment Terms:

T/T, WU

Production Capacity:

500Ton/year

Min. Order:

1 Gram

Packing:

according to the customer's requirements 

Means of Transport:

Ocean, Air, Land

Delivery Date:

7 days

 

Cilnidipine

CAS: 132203-70-4

Item

Index

Molecular Formula

C27H28N2O7

Molecular Weight

492.52

Specification

CP/USP/EP

Melting point

97-99°C

 

Medical uses

CILNIDIPINE due to its blocking action at N-type calcium channel dilates both arteriole & venules as a result the pressure in the capillary bed is reduces. The accumulated fluid in the tissues flows back to veins & thus Cilnidipine minimizes the incidence of pedal edema.

 


PRODUCT INQUIRY
If you would like to have a question then get in touch today, we are ready to assist 24/7.
We welcome your cooperation and we will develop with you.
Factory-direct Connectivity Solutions.
High quality, Competitive Price.
Custom-tailored solutions.
Problem-solving approach.

OUR PRODUCT/SERVICE

MOSINTER GROUP was established in 2004. The main office is located in Ningbo, China. The production are located in Zhejiang Province, Jiangsu Province and Shandong Province in China. Specializing in the production and marketing of chemical products, MOSINTER GROUP has excellent production equipment and a high-performing sales team as well as advanced manufacturing technique, comprehensive quality management system and modernized testing methods.

QUICK LINK

CONTACT INFO

  0086-18989305995
 0086-574-88212215
  sales@mosinterchem.com
  YinXianDaDao 1357, Guangbo Center Office 2003, Ningbo, Zhejiang, China
 forwardcy
 0086-18989305995
 0086-18989305995
Copyright  2020 Mosinter Group Limited All rights reserved.